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Summary
Objective: In order to examine the biological activity of low-dose and continuously
infused superantigen, and to establish a superantigen-induced multiple organ dys-
function animal model, several pathophysiological parameters were sequentially
monitored in a toxin-concentration-controlled pig model.
Methods: Anesthetized, mechanically ventilated and Swan—Ganz thermodilution
catheter-inserted pigs were treated with toxic shock syndrome toxin-1 (TSST-1) by
infusion at 2 mg/kg/h for 5 h. Monitoring was performed for both the infusion period
and a subsequent 1-h post-infusion period.
Results: The serum concentration of TSST-1 was controlled so as to elevate it to a
level over 1000 pg/mLwithin 1 h of initiation of infusion, and then gradually increased
further and reached a plateau of about 2500 pg/mL at 4 h after initiation. The animals
showed a significant increase in cardiac output, the intrapulmonary arteriovenous
shunt ratio, and infiltration of white blood cells into the lung. Although the observed
increase in pulmonary vascular resistance was not statistically significant, it did
correlate with the reduction in white blood cell counts.* Corresponding author. Tel.: +81 77 533 8358; fax: +81 77 533 8342.
E-mail address: keishi_miwa@nts.toray.co.jp (K. Miwa).
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Superantigen-induced multiple organ dysfunction in swine sepsis model 15Conclusion: The superantigen TSST-1 plays an important role in the pathogenesis of
Gram-positive bacterial sepsis by inducing multiple organ dysfunction. Thus, this
model provides the first tool to allow the simultaneous examination of the serum toxin
levels and other organ parameters in a time-course manner.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.Introduction
Sepsis is a principal cause of death in critical care
units worldwide.1—3 In particular, Gram-positive
sepsis accounts for 50% of serious sepsis cases.4
Despite considerable progress in understanding
the central role of lipopolysaccharide (LPS) in the
pathogenesis of Gram-negative septic shock,5—8 the
pathogenesis of Gram-positive bacterial sepsis
remains only poorly understood. Accumulating evi-
dence suggests that the pathogenesis of Gram-posi-
tive sepsis is different from that of Gram-negative
sepsis.9,10
Unlike the case with Gram-negative sepsis, it is
believed that endotoxin is not an essential mediator
in the toxic shock syndrome (TSS) associated with
Gram-positive bacterial infections.11 Although sev-
eral bacterial products, such as peptidoglycan,12,13
lipoteichoic acid,12,13 and superantigens,14 have
been postulated as pathogenic toxins responsible
for Gram-positive sepsis, no conclusive evidence has
yet been obtained.
Among these bacterial products, toxic shock syn-
drome toxin-1 (TSST-1), a superantigenic protein
produced by Staphylococcus aureus, is the most
extensively studied to date in terms of its patho-
genic properties, and it has been studied in a variety
of animal models.15 In animal studies,16—18 it has
been shown that TSST-1 alone at relatively low doses
can induce TSS-like symptoms indicative of circula-
tory and respiratory failure, but exerts lethal
effects only at relatively large doses unless endo-
toxin is co-administered. Furthermore, TSST-1 has
been shown to significantly enhance the lethal
effects of endotoxin.19 These findings suggest that
the primary role of TSST-1 in the pathogenesis of
Gram-positive sepsis is not an induction of refrac-
tory systemic hypotension, but rather, the develop-
ment of multiple organ dysfunction as the
precipitating event to hypotension. Thus, if this
suggestion were to be borne out, it would be more
important to focus on the biological processes which
trigger the multiple organ dysfunction seen prior to
the ultimately lethal event in order to gain a better
understanding of the pathogenesis of, and potential
therapeutic intervention in, Gram-positive sepsis.
In this vein, it is noteworthy that apparent spe-
cies differences can be observed in terms of thesusceptibility to develop TSS-like symptoms upon
artificial infection with Staphylococcus aureus or
intravenous doses of TSST-1.15 Rabbits18 and pigs20
are highly susceptible species, while mice21 and
monkeys22 do not exhibit any significant TSS-like
symptoms. Accordingly, rabbits are the most widely
used model animals for Gram-positive bacterial
sepsis. Rabbits, however, are relatively small in size,
and their circulating blood volume is scant. Thus, it
is technically too difficult to perform repeated
blood sampling from the same rabbits without hav-
ing a negative effect on their physical well-being. A
further negative feature is that special devices are
required for proper time-course monitoring of the
rabbits’ cardiac and respiratory functions.
Since miniature pigs have been shown to be
sensitive to TSST-1,20 and superantigen-induced
expansion is inducible in pig T-helper cells,23 and
also that cytokine is inducible by superantigens from
the peripheral blood mononuclear cells of normal
pigs,24 conventional pigs were selected as themodel
animals, most especially because the frequent
repeated blood sampling required for the time-
coursemonitoring of hematological and biochemical
changes would affect the animals’ physiological
condition only to a negligible extent. In addition,
pigs are sufficiently large that it is possible to use
conventional clinical devices used for the monitor-
ing of such parameters in human patients to monitor
the animals’ cardiac and respiratory functions.
The present study reports a superantigen-
induced multiple organ dysfunction model devel-
oped in conventional pigs by continuous infusion
of TSST-1. The TSST-1 concentration in the blood
was controlled during the investigation. Time-
course changes in cardiac and respiratory function
are described in relation to changes in hematology
and blood chemistry in these model animals.Materials and methods
Toxins
Toxic shock syndrome toxin-1 (TSST-1) was chroma-
tographically purified from the culture supernatants
of the Staphylococcus aureus FRI1169 strain, as
described by Igarashi et al.25 The purified prepara-
16 K. Miwa et al.tion gave a single band on SDS gel electrophoresis
with coomassie brilliant blue staining. The purified
TSST-1 had undetectable levels of lipopolysacchar-
ide (LPS) (limits of detection <5 pg/mg TSST-1), as
judged by limulus assay.
TSST-1 was diluted to give a concentration of
10 mg/mL, with physiological saline supplemented
with 5% swine auto-serum. The solution was filtered
through a 0.22-mm filter before use in the infusion
treatment of animals.
Animals
Ten conventional Landrace male pigs weighing 25—
35 kg (age 2—3 months) were obtained from a local
supplier. The anti-TSST-1 IgG antibody and anti-
TSST-1 IgM antibody levels were below the detection
limit, as judged by ELISA. LPS in the blood stream
was also below the detection limit (<5 pg/mL).
These animals were divided into two groups, and
a statistical difference in mean body weight was not
observed, 29.5  4.6 (TSST-1 infused group) versus
28.6  2.8 (control group).
Treatment of animals
The study protocol was reviewed and approved by
the institutional animal research committee of both
the Tokyo Medical College and Specialty Material
Research Laboratories of Toray Industries, Inc.
Surgical procedure
Each animal was anesthetized by intramuscular
administration of ketamine (17 mg/kg) and atropine
sulfate (0.03 mg/kg). The animal was maintained
under anesthesia by mechanical ventilation with an
oxygen-enriched air mixture containing 1% isoflur-
ane (inspired oxygen fractional concentration
(FIO2 = 0.80) at a tidal volume of 10 mL/kg and a
respiration rate of 15 strokes/min) by means of a
Servo Model 900D ventilator (Siemens—Elema,
Stockholm, Sweden). The animal was also main-
tained under conditions of a constant body fluid
balance by continuous infusion of physiological sal-
ine at 3 mL/kg/h from the epiotic vein. The right
carotid artery was cannulated for monitoring arter-
ial blood pressure and heart rate (HR) and for the
sampling of the arterial blood samples, which were
subjected to blood gas analysis, hematology, and
blood chemistry. One of the jugular veins was can-
nulated with a Swan—Ganz Opticath thermodilution
catheter (Abbott Inc., Abbott Park, IL) for monitor-
ing cardiac output. The oxygen saturation of mixed
venous blood (SVO2) was measured with an Oxyme-
trix 3 (Abbott Inc., Redwood City, CA). The monitor-
ing of the pulmonary arterial pressure, centralvenous pressure, and pulmonary capillary wedge
pressure was carried out with a Model 54 S analyzer
(Hewlett Packard, Palo Alto, CA), and the mixed
venous blood samples were subjected to blood gas
analysis. The infusion port of the thermodilution
catheter was connected to an infusion line unit
having two injection ports: one for continuous infu-
sion of physiological saline at 3 mL/kg/h to maintain
the fluid balance in the animal and the other for
continuous infusion of TSST-1. After the connection
was completed, the animal was maintained under
continuous infusion of physiological saline via the
thermodilution catheter rather than via the epiotic
vein, and mechanical ventilation was carried
out with an air mixture (FIO2 = 0.21) containing 1%
isoflurane for recovery from the effects of the
surgery.
Cardiac and respiratory monitoring indicated
that all animals undergoing the surgical operation
described above recovered from the effects
of surgery within 30 min of completion. Thus, the
normal baseline levels of the parameters were
recorded at 30 min after completion of surgery:
HR = 100  15 beats/min, mean arterial pressure
(MAP) = 90  10 mmHg, and arterial oxygen partial
pressure (PaO2) = 90  10 torr [12  1.3 kPa], and
SVO2 = 70  10%.
After the baseline values of the cardiac and
respiratory function parameters were recorded,
animals were divided into two groups, the toxin
infusion group and the control group. In the toxin
infusion group, TSST-1 solution (10 mg/mL) was
infused and in the control group, saline was infused
both at 0.2 mL/kg/h for 5 h through the infusion
tube of the thermodilution catheter. The cardiac
and respiratory function parameters were moni-
tored continuously for 6 h from the initiation of
the TSST-1 continuous infusion. After 6 h, the arter-
ial catheter and thermodilution catheter were with-
drawn, the wounds were closed surgically, and the
animals were sacrificed with a lethal dose of sodium
pentobarbital.
Measurements
Serum TSST-1 levels were determined by enzyme-
linked immunosorbent assay (ELISA) with a detec-
tion limit of 10 pg/mL, as previously reported.26
Serum anti-TSST-1 IgG or IgM antibodies were deter-
mined by ELISA. Serum was diluted 1000-fold to
avoid non-specific reactions and then applied to a
TSST-1 immobilized ELISA plate. Then anti-TSST-1
antibodies were detected by anti-swine IgG (KPL
Inc., Gaitherburg, MD) or IgM (Serotec Ltd, Oxford,
United Kingdom) antibodies. LPS was measured with
a commercially available limulus assay kit (Wako
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Figure 1 Time-course changes in mean concentrations
of toxins (panel A) and cytokines (panel B) in the arterial
blood during the 5-h infusion of toxic shock syndrome
toxin-1 (TSST-1) and the subsequent 1-h post-infusion
observation period. Five conventional pigs were continu-
ously treated with TSST-1 at 2 mg/kg/h for 5 h. Panel A:
TSST-1 (closed circles) and endotoxin (open circles). Panel
B: gamma interferon (IFN-g) (closed circles) and tumor
necrosis factor a (TNF-a) (open circles).Pure Chemicals, Osaka, Japan). Cytokines were
quantitated with a colorimetric ELISA kit (Endogen
Inc., Woburn, MA). Blood gas analysis was performed
on an ABL-520 blood gas analyzer (Radiometer,
Copenhagen, Denmark), and the measured values
were standardized for body temperature. Hemato-
logical parameters and blood chemistry parameters
were determined by standard methods at Tokyo
Medical School, Hachioji Medical Center.
Histopathology
For histopathological examination, two pigs (one
TSST-1 infused pig and one control pig) were sub-
jected to euthanasia and necropsy 6 h after the
initiation of the TSST-1 (or saline) infusion. The
lungs were removed from the body of each animal.
The tissues were cut into small sections, fixed in 10%
neutral buffered formalin, and embedded in paraf-
fin. Thin sections of the tissues were prepared and
stained with hematoxylin and eosin for microscopic
examination.
Statistical analysis
All data are presented as the mean  standard
deviation of five animals in each group. For each
parameter, statistical significance of the difference
between the baseline value and the value at 6 h
after the initiation of the TSST-1 infusion was tested
by paired t-test, and statistical significance of the
difference between the TSST-1 infused group and
the control group was tested by Student’s t-test
using the parameters at 6 h. In both comparisons,
significant differences were tested at a significance
level of 0.05. Correlations between the parameters
were tested by regression analysis at a significance
level of p < 0.05.Results
When conventional pigs were treated with TSST-1
alone by continuous infusion at 2 mg/kg/h for 5 h, no
deaths were observed either during the 5-h TSST-1
infusion period or during the 1-h post-infusion obser-
vation period. In addition, none of the animals
exhibited thrombocytopenia, rash, diarrhea, or
vomiting.
Serum TSST-1 rapidly increased in these animals
during the initial 1-h period of the TSST-1 infusion
and appeared to reach a plateau of 2639  846 pg/
mL at 4 h after initiation (Figure 1A). Serum TSST-1
decreased on completion of the infusion, and the
level was determined to be 1244  419 pg/mL at 1 h
after completion.Serum gamma interferon (IFN-g) became detect-
able at 2 h after initiation and reached a maximum
level of 217  135 pg/mL at completion of the infu-
sion (Figure 1B). Serum IFN-g, however, did not
exhibit any significant decline at 1 h after comple-
tion.
Neither endotoxin nor tumor necrosis factor
alpha (TNF-a) were detected in the arterial blood
from any of the animals at any time point during the
5-h infusion period or the subsequent 1-h observa-
tion period.
When animals were treated with physiological
saline in place of TSST-1, neither toxins nor cyto-
kines were detected in the serum at any time point
during the 5-h infusion period or the subsequent 1-h
observation period (data not shown). In these ani-
mals, no significant changes were detected in any of
the cardiac and respiratory function parameters on
the one hand or on the other hand, in any of the
hematological and biochemical parameters, except
for a slight increase of blood urea nitrogen, as
described below (Figures 2—5, open circle).
Cardiac function
The changes in cardiac function parameters in pigs
treated with continuous infusion of TSST-1 are pre-
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Figure 2 Time-course changes in cardiac parameters during the 5-h infusion of toxic shock syndrome toxin-1 (TSST-1)
and subsequent 1-h post-infusion observation period. (*): TSST-1 infused group, (*): control group. HR: heart rate; CO:
cardiac output; SV: stroke volume; MAP: mean arterial pressure. Data are expressed as mean  SD. *: p < 0.05 (TSST-1
infused group versus control group at 6 h by Student t-test); **: p < 0.05 (0 h versus 6 h in TSST-1 infused group by paired t-
test).sented in Figure 2. In these animals, heart rate (HR)
and cardiac output (CO) gradually increased during
the first 3-h period of the TSST-1 infusion and
remained at significantly increased levels even
at 1 h and 6 h after completion of the infusion.
In contrast, the stroke volume (SV) gradually
decreased during the 5-h infusion period and theFigure 3 Time-course changes in respiratory parameters dur
1) and subsequent 1-h post-infusion observation period. (
intrapulmonary arteriovenous shunt ratio; DO2: oxygen delive
saturation; VO2: systemic oxygen consumption. Data are exp
versus control group at 6 h by Student t-test); **: p < 0.05 (0subsequent 1-h observation period. The SV at the
end of the observation periodwas significantly lower
than the baseline; however, no difference between
the TSST-1 infused and control groups was observed
at the 6 h time point. Mean arterial pressure in the
TSST-1 infused group tended to increase, but the
values at the end of the observation period were noting the 5-h infusion of toxic shock syndrome toxin-1 (TSST-
*): TSST-1 infused group, (*): control group. Qs/Qt:
ry; PaO2: arterial oxygen pressure; SaO2: arterial oxygen
ressed as mean  SD. *: p < 0.05 (TSST-1 infused group
h versus 6 h in TSST-1 infused group by paired t-test).
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Figure 4 Time-course changes in oxygen metabolism parameters during the 5-h infusion of toxic shock syndrome toxin-
1 (TSST-1) and subsequent 1-h post-infusion observation period. (*): TSST-1 infused group, (*): control group. pH:
arterial blood pH; BE: base excess; HCO3
: bicarbonate ion concentration; AKBR: arterial ketone body ratio. Data are
expressed as mean  SD. **: p < 0.05 (0 h versus 6 h in TSST-1 infused group by paired t-test).significantly higher than the baseline values or the
control group. No other parameters, such as body
temperature, pulmonary arterial pressure, pulmon-
ary capillary wedge pressure, central venous pres-Figure 5 Time-course changes in biochemical and hemato
syndrome toxin-1 (TSST-1) and subsequent 1-h post-infusion ob
group. TP: total protein; BUN: blood urea nitrogen; RBC: red b
hematocrit value standardized white blood cell count. *: p <
Student t-test), **: p < 0.05 (0 h versus 6 h in TSST-1 infusedsure, left ventricle stroke work, right ventricle
stroke work, pulmonary vascular resistance, or sys-
temic vascular resistance exhibited any significant
changes (data not shown).logical parameters during the 5-h infusion of toxic shock
servation period. (*): TSST-1 infused group, (*): control
lood cell count; Ht: hematocrit; Hb: hemoglobin; WBC/Ht:
0.05 (TSST-1 infused group versus. control group at 6 h by
group by paired t-test).
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Figure 6 Correlation between the changes in pulmonary
vascular resistance (DPVR) and the white blood cell count
(DWBC).Respiratory function
The changes in the respiratory function parameters
in the animals that received TSST-1 are shown in
Figure 3. The intrapulmonary arteriovenous shunt
ratio (Qs/Qt), and oxygen delivery (DO2) had sig-
nificantly increased in the animals at 1 h after com-
pletion of the infusion, and statistically significant
differences between the TSST-1 infused group and
the control group were also observed. In addition,
arterial oxygen partial pressure (PaO2), arterial oxy-
gen saturation (SaO2) and systemic oxygen consump-
tion (VO2) all exhibited significant changes at 1 h
after completion of the TSST-1 infusion when the
values were compared with the baseline; however,
the differences between the TSST-1 infused and
control groups at the time point of 6 h were not
statistically significant. No significant changes were
observed in arterial carbon dioxide pressure, sys-
temic oxygen extraction ratio, respiratory index,
mixed venous blood oxygen saturation or alveolar
arterial oxygen difference (data not shown).
Oxygen metabolism
The serum lactate concentration was significantly
increased at 1 h after completion of the TSST-1
infusion when compared with the baseline level
(Figure 4). Other than this increase, all of the
parameters concerning oxygen metabolism, arterial
blood pH (pH), base excess (BE), bicarbonate ion
concentration (HCO3
) and arterial ketone body
ratio (AKBR), were found to be decreased at 1 h
after completion of the TSST-1 infusion. However,
the differences between the TSST-1 infused and
control groups were not statistically significant.
Blood chemistry
Among the blood chemistry parameters examined,
a slight but statistically significant increase was
noted for the total protein concentration (TP) at
1 h after completion of the TSST-1 infusion when
compared with the baseline level (Figure 5). How-
ever, the difference between the TSST-1 infused
and control groups was not statistically significant.
In addition, a moderate but statistically significant
increase was observed in both the TSST-1 infused
and control groups in the blood urea nitrogen
(BUN) concentration. Also, BUN concentrations
at the 6 h time point were statistically different
between the TSST-1 infused and control groups.
However, the creatinine level exhibited no signifi-
cant elevation in either group (data not shown).
None of the other parameters, including alanine
aminotransferase, aspartate aminotransferase,glucose, creatine phosphokinase, amylase, or elec-
trolytes exhibited any significant changes in level
(data not shown).
Hematology
Significant increases were noted in red blood cell
count (RBC), hematocrit (Ht), and hemoglobin con-
centration (Hb) in the animals at 1 h after comple-
tion of the TSST-1 infusion when compared with the
baseline level (Figure 5). In contrast, the white
blood cell count was observably, but not signifi-
cantly, decreased in these animals. Statistical sig-
nificance, however, was detected for the white
blood cell count when the values were standardized
with the hematocrit values (WBC/Ht) (Figure 5).
However, the difference of WBC/Ht between the
TSST-1 infused and control groups was not statisti-
cally significant at the 6 h time point. In addition,
the decrease in white blood cell count (DWBC) did
significantly correlate with the increase in pulmon-
ary vascular resistance (DPVR) (Figure 6). The pla-
telet count did not exhibit any significant change
(data not shown).
Histopathology
Histopathological comparison between the TSST-1
infused pig (Figure 7A) and the control pig
(Figure 7B) revealed five characteristic changes.
First there was an increased amount of neutrophil
infiltration into the intra-alveolar septa (yellow
arrow), and second, mononuclear cell infiltration
into the intra-alveolar septa (green arrow). The
third visible change is hemorrhage (red blood cells
in the alveolae, black arrow), and the fourth is
macrophage infiltration into the alveolae (white
arrow). The fifth change is the thickening of the
intra-alveolar septa. In control pigs, only a small
number of neutrophils were found in the intra-
alveolar septa and thickening of the intra-alveolar
septa was not observed.
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Figure 7 Histopathological observation of lung. A thin section of the tissue was stained with hematoxylin and eosin
(magnification: 50). (A) In TSST-1 infused pig, increased infiltration of neutrophils into the intra-alveolar septa (yellow
arrow), mononuclear cell infiltration into the intra-alveolar septa (green arrow), hemorrhage (red blood cells in the
alveolae, black arrow), macrophage infiltration into the alveolae (white arrow), and thickening of the intra-alveolar
septa were observed. (B) In the control pig, only a small number of neutrophils were found in the intra-alveolar septa and
thickening of the intra-alveolar septa was not observed.Discussion
For investigations into the pathogenesis of Gram-
positive bacterial sepsis, a variety of animal models
have been utilized which monitor death as the pri-
mary endpoint.15 Because of their high susceptibility
to TSST-1 toxicity, rabbits have been the most widely
used model animals.16—18 In rabbits, the induction of
lethal hypotension requires relatively large doses of
TSST-1 unless endotoxin is co-administered. Similar
results have been reported in a recent study in
miniature pigs.20 These results suggest that the
immediate role of TSST-1 in the pathogenesis of
Gram-positive bacterial sepsis is to induce cardiac
and respiratory failure rather thanprimary refractory
systemic hypotension. Accordingly, we have focused
on the initial stage of the biological process induced
by continuous infusionof TSST-1. In thepresent study,
we observed animals for a 6-h period: the 5-h infusion
period and a subsequent 1-h follow-up observation
period. This is because a preliminary experiment had
revealed that significant changes were detectable in
certain parameters 1-h post-infusion.
In order to examine the biochemical process
leading to multiple organ dysfunction, it is neces-
sary to simultaneously monitor several parameters
in a time-course manner at once. Such parameters
include cardiac and respiratory function, hematol-
ogy, blood chemistry, serum toxin levels, and serum
cytokine levels. Carrying out such simultaneous
monitoring without affecting physiological condi-
tions, however, is extremely difficult with small
laboratory animals, such as rabbits, because of
the limited quantity of circulating blood. Accord-
ingly, no time-course data have been forthcoming in
these model animals, especially in terms of a cor-
relation of the serum TSST-1 levels and changes in
these parameters.Hence, pigs were selected as the model animals
since pigs have been shown to be sensitive to TSST-1
toxicity20,23,24 and are also of sufficient size to with-
stand the multiple sampling required. In the present
study, conventional pigs were treated with TSST-1
alone by continuous infusion in an effort to develop
a model for the superantigen-induced multiple
organ dysfunction observed in patients with
Gram-positive bacterial sepsis. A thermodilution
catheter was inserted into the jugular vein to allow
continuous monitoring of cardiac function para-
meters and also mixed venous blood sampling. A
normal catheter was also inserted into the carotid
artery for blood pressure monitoring and a 15-mL
blood sampler for blood gas, hematology, and blood
chemistry measurements. All parameters were
determined at baseline and at 1-h intervals for
6 h after the initiation of the TSST-1 infusion.
As expected, repeated blood sampling by itself
did not significantly affect the animals when they
were treated with physiological saline in place of
TSST-1 (Figures 2—5).
The dose selection was based on a dose-finding
study performed prior to the present study (data
not shown). As previously reported by our labora-
tory27 and others,28 serum superantigen levels are
found in the range of 1000—5000 pg/mL in most
patients afflicted with Gram-positive bacterial
sepsis. The dose-finding study revealed that con-
tinuous infusion of TSST-1 at 2 mg/kg/h could give
serum TSST-1 levels in a range similar to that
reported in TSS patients. In fact, in this study,
continuous infusion at this dose resulted in a rapid
increase in serum TSST-1 during the initial 1-h
period of the TSST-1 infusion and then the serum
TSST-1 levels reached a range similar to that
reported with TSS patients at 4 h after the initia-
tion of the infusion (Figure 1A).
22 K. Miwa et al.Since conventional pigs were used, endotoxin
translocated from the gut flora might have been
detectable in the circulating blood. No detectable
levels of serum endotoxin, however, were demon-
strated in the animals at any of the time points
examined in this study (Figure 1A). Thus, it is con-
sidered that endotoxin plays only a negligible role, if
any, in this model.
In the animals treated with TSST-1, serum IFN-g
increased while serum TNF-a remained undetect-
able throughout the observation period. These
results are apparently inconsistent with the hypoth-
esis postulated by Miethke et al.29 that an elevation
of TNF-a occurs at a very early stage and triggers the
subsequent cytokine storm and lethal hypotension.
In the present study, post-infusion observation
was performed for only 1 h. Accordingly, neither
deaths nor TSS-like symptoms, such as diarrhea,
vomiting, erythema, hypotension, or thrombocyto-
penia, were observed in the animals treated with
TSST-1. These results are consistent with the report
by Bulanda and coworkers.20
To evaluate the sensitivity of pigs to TSST-1, LPS
lethality enhancement capacity19 was examined in
the TSST-1 infused pigs. LPS was infused 1 h after
TSST-1 infusion terminated, at a concentration of
10 mg/kg/h for 1 h. This LPS concentration was of
non-lethal level; however, when pigs were pre-trea-
ted with TSST-1 at the same dose in the experiment,
all animals died within 24 h (data not shown).
Furthermore, TNF-a in the blood became elevated
after the LPS infusion. These results indicate that
pigs were sensitive enough to respond to TSST-1
even at this low infusion dose, and as expected,
do respond with a burst of TNF-a.
Constant infusion of TSST-1-induced three major
dysfunctions in pigs: (a) a cardiac disorder charac-
terized by an increase of HR and CO (Figure 2), (b) a
respiratory disorder characterized by an increase in
Qs/Qt and DO2 (Figure 3), and (c) infiltration of
white blood cells into the intra-alveolar septa,
and these findings were significantly different
between the TSST-1 infused and control groups.
Furthermore, TSST-1-induced five minor changes
in pigs: (a) a reduction of SV that suggests a cardiac
disorder (Figure 2), (b) a decrease of PaO2 and SaO2
that suggests a respiratory disorder (Figure 3), (c) an
increase in the arterial lactate concentration
(Figure 4), AKBR (Figure 4), and VO2 (Figure 3)
that suggest oxygen metabolism disorders, (d) a
decrease in white blood cell (WBC) counts that,
standardized with the hematocrit values, suggests
inflammation, and (e) an increase in the hematocrit
values which suggests capillary leakage. All of these
parameters were significantly different when com-
pared with the baseline level at 1 h after completionof the TSST-1 infusion, although the differences
between the TSST-1 infused group and the control
group were not statistically significant.
The increase in arterial lactate resulted in meta-
bolic acidosis. For compensation of this high-oxygen
consumption, it was assumed that CO increased in
an effort to increase oxygen delivery in the animals
(Figure 2), and the oxygen extraction ratio remained
constant. The increased cardiac output (high-output
state) was probably a result of tachycardia,
although myocardial depression and capillary leak-
age were suggested from the decrease in SV
(Figure 2) and the increase in hematocrit
(Figure 5). A high-output state might also be a result
of hypoxia, as evidenced by the increase in Qs/Qt
(Figure 3). These results suggest respiratory dys-
function characterized by inefficient gas exchange.
The serum IFN-g level was observed to increase
in the animals (Figure 1B). Since IFN-g is known to
activate T cells, especially Th1 helper T cells, the
activation of leukocytes might be involved in the
state of inefficient gas exchange. This was sup-
ported by histopathological findings that mononuc-
lear cells and an increased number of neutrophils
had infiltrated into lung tissue (Figure 7). When the
white blood cell count was standardized with the
hematocrit values (WBC/Ht), it was found to have
significantly decreased after TSST-1 infusion
(Figure 5). Furthermore, decreases in the WBC
count observed in individual animals for the entire
6-h observation period had a statistically signifi-
cant correlation with an increase in pulmonary
vascular resistance during the same period
(Figure 6). These results indicate that the acti-
vated WBC, which infiltrated into the lung,
insulted the tissue (this being observed as hemor-
rhage and a thickening of the intra-alveolar septa)
and may have triggered the respiratory disorder. It is
certainly likely to have contributed to it. Arad et al.30
have also reported the activation of Th1 helper
Tcells with superantigen. However, the specific rela-
tionship between certain activated species of
immune cells and species of superantigens is still
controversial. Herz et al.31 have reported that an
airway exposure model of a superantigen, staphylo-
coccal enterotoxin B, resulted in an increase in serum
interleukin4, a cytokineproducedbyTh2typeTcells,
but not in a production of IFN-g. In the near future,
when we are able to obtain the necessary anti-swine
antigen antibodies, more details of the mechanism
will be elucidated by immunostaining and/or flow-
cytometry.
In addition to the changes described above, blood
chemistry revealed a mild but significant increase in
blood urea nitrogen (BUN) in the animals (Figure 5).
However, while an elevated BUN was also observed
Superantigen-induced multiple organ dysfunction in swine sepsis model 23in control animals, the BUN concentration at the 6 h
time point was significantly low in control animals,
suggesting an early stage of renal failure. TSST-1 has
previously been reported to exert some degree of
renal toxicity in rabbits.18
In conclusion, we have developed a swine sepsis
model to help evaluate the pathogenic mechanisms
of TSST-1-induced multiple organ dysfunction. The
serum TSST-1 level is readily controllable in this
model. In addition, simultaneous and continuous
monitoring of cardiac and respiratory function para-
meters, together with repeated blood sampling, can
readily be performed. Thus, this model provides the
first tool capable of simultaneously examining both
the serum toxin levels and other parameters in a
time-course related manner.
As described above, myocardial depression,
tachycardia, acute lung injury, capillary leakage,
and renal impairment were all observed in the
model. These symptoms are well known in human
toxic shock syndrome.4,21 Neither a high dose of
TSST-1 nor an infusion of protracted duration was
required for the induction of organ failure. Thus,
this study provides an animal model for Gram-posi-
tive bacterial sepsis without lethal hypotension.
This model should prove to be of considerable value
not only in studies geared to a better understanding
of pathogenesis, but also for the development of
therapeutic interventions of the early septic state
without attendant shock.Acknowledgments
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